TREX2 and head and neck squamous cell carcinoma: Remarkably, Manils et al. demonstrated deregulated TREX2 expression in squamous carcinomas by IHC analysis of human samples of head and neck squamous cell carcinoma (HNSCC), cutaneous squamous cell carcinomas (CSCCs) and precancerous actinic keratosis lesions.